News

Feazell & Tighe, a law firm has filed a lawsuit in the US District Court for the Southern District of Texas on behalf of all persons or entities

Stratatech has reported that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European

The team’s analysis of four microRNAs (miRNA) found in the blood plasma of pancreatic cancer patients is proof of principle to further develop a blood test for this

Sucampo Pharma Europe, a wholly-owned subsidiary of Sucampo Pharmaceuticals has reported the withdrawal of its European marketing authorisation application (MAA) for lubiprostone, 24mcg. Lubiprostone is indicated for the

Takeda has reported that its wholly-owned subsidiary, Takeda Global Research & Development Center has received a complete response letter from FDA regarding the New Drug Application (NDA) for

Elekta has reported that it will provide treatment planning and information management systems to Ion Beam Applications (IBA) for a Proton Therapy facility in Prague. The software is

FDA has accepted to review Takeda’s supplemental new drug application (sNDA) based on long-term overall survival (OS) data from the VISTA 1 trial. The study examined the use

Vical Incorporated (Vical) has reported the issuance of US Patent No. 7,582,613 covering Vaxfectin-formulated DNA vaccines for influenza. The company said that the patent provides broad coverage for

Algeta has entered into a global agreement with Bayer for the development and commercialisation of the former’s first-in-class alpha-pharmaceutical, Alpharadin. Alpharadin is Algeta’s lead cancer therapeutic. It is